CapsoVision (CV) Gains from Investment Securities (2024)
CapsoVision's (CV) quarterly Gains from Investment Securities came in at -$3000.0 in Q4 2024, down 160.0% quarter-over-quarter from $5000.0 in Q3 2024.
CapsoVision (CV) Gains from Investment Securities (2024) Analysis & Trends
CapsoVision has disclosed Gains from Investment Securities across 1 years of filings, most recently posting -$3000.0 for Q4 2024.
- Gains from Investment Securities for Q4 2024 came in at -$3000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2000.0 (changed N/A YoY), and the FY2024 annual result was -$1000.0, changed N/A from the prior year.
- Gains from Investment Securities came in at -$3000.0 for Q4 2024 at CapsoVision, down from $5000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5000.0 in Q3 2024 to a low of -$3000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | CapsoVision | 176.55 Mn | 166.44 Mn | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |